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Phosphoramide mustard exposure induces DNA adduct formation and
the DNA damage repair response in rat ovarian granulosa cells
Abstract
Phosphoramide mustard (PM), the ovotoxic metabolite of the anti-cancer agent cyclophosphamide (CPA),
destroys rapidly dividing cells by forming NOR-G-OH, NOR-G and G-NOR-G adducts with DNA,
potentially leading to DNA damage. A previous study demonstrated that PM induces ovarian DNA damage in
rat ovaries. To investigate whether PM induces DNA adduct formation, DNA damage and induction of the
DNA repair response, rat spontaneously immortalized granulosa cells (SIGCs) were treated with vehicle
control (1% DMSO) or PM (3 or 6 μM) for 24 or 48 h. Cell viability was reduced (P < 0.05) after 48 h of
exposure to 3 or 6 μM PM. The NOR-G-OH DNA adduct was detected after 24 h of 6 μM PM exposure,
while the more cytotoxic G-NOR-G DNA adduct was formed after 48 h by exposure to both PM
concentrations. Phosphorylated H2AX (γH2AX), a marker of DNA double stranded break occurrence, was
also increased by PM exposure, coincident with DNA adduct formation. Additionally, induction of genes
(Atm, Parp1, Prkdc, Xrcc6, and Brca1) and proteins (ATM, γH2AX, PARP-1, PRKDC, XRCC6, and
BRCA1) involved in DNA repair were observed in both a time- and dose-dependent manner. These data
support that PM induces DNA adduct formation in ovarian granulosa cells, induces DNA damage and elicits
the ovarian DNA repair response.
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Abstract
Phosphoramide mustard (PM), the ovotoxic metabolite of the anti-cancer agent cyclophosphamide 
(CPA), destroys rapidly dividing cells by forming NOR-G-OH, NOR-G and G-NOR-G adducts 
with DNA, potentially leading to DNA damage. A previous study demonstrated that PM induces 
ovarian DNA damage in rat ovaries. To investigate whether PM induces DNA adduct formation, 
DNA damage and induction of the DNA repair response, rat spontaneously immortalized 
granulosa cells (SIGCs) were treated with vehicle control (1% DMSO) or PM (3 or 6 μM) for 24 
or 48 h. Cell viability was reduced (P < 0.05) after 48 h of exposure to 3 or 6 μM PM. The NOR-
G-OH DNA adduct was detected after 24 h of 6 μM PM exposure, while the more cytotoxic G-
NOR-G DNA adduct was formed after 48 h by exposure to both PM concentrations. 
Phosphorylated H2AX (γH2AX), a marker of DNA double stranded break occurrence, was also 
increased by PM exposure, coincident with DNA adduct formation. Additionally, induction of 
genes (Atm, Parp1, Prkdc, Xrcc6, and Brca1) and proteins (ATM, γH2AX, PARP-1, PRKDC, 
XRCC6, and BRCA1) involved in DNA repair were observed in both a time- and dose-dependent 
manner. These data support that PM induces DNA adduct formation in ovarian granulosa cells, 
induces DNA damage and elicits the ovarian DNA repair response.
Keywords
Cyclophosphamide; Phosphoramide mustard; DNA adduct; DNA damage; DNA repair; Granulosa 
cells
Introduction
Infertility is a side effect of female cancer treatment. Female cancer treatment survivors have 
reduced fecundity, relative to their non-treated counterparts (Hudson, 2010). In addition, 
cancer treatment can reduce the ovarian follicular reserve, resulting in premature ovarian 
failure (POF) (Hudson, 2010). Fewer primordial follicles have been demonstrated in 
autopsied ovarian samples (Himelstein-Braw et al., 1977) and fewer antral follicles detected 
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by ultrasound (Larsen et al., 2003) in females that received anti-neoplastic treatment 
compared to their age-matched control subjects.
Cyclophosphamide (CPA) is an alkylating agent used to treat both cancer and autoimmune 
disorders. CPA causes acute ovarian failure in childhood cancer survivors (Chemaitilly et al., 
2006) and rapid amenorrhea in women undergoing adjuvant treatment for breast cancer 
(Minton and Munster, 2002). CPA is a pro-drug requiring hepatic biotransformation by 
cytochrome P-450 enzymes, to generate an active cytotoxic metabolite, phosphoramide 
mustard (PM) (Madden et al., 2014; Plowchalk and Mattison, 1991). PM is the anti-
neoplastic as well as the ovotoxic metabolite of CPA (Desmeules and Devine, 2006; Petrillo 
et al., 2011). PM causes primordial and small primary follicle loss (Petrillo et al., 2011), and 
a volatile metabolite of PM, chloroethylaziridine (CEZ) is also likely involved in PM-
induced ovotoxicity (Madden et al., 2014).
PM induces DNA or chromosomal damage in mammalian cells, which could be considered 
as genotoxicity markers (Anderson et al., 1995). PM is also an alkylating agent, known to 
cause cytotoxicity through forming cross-linked DNA adducts which inhibit DNA strand 
separation during replication (Phillips et al., 2000). DNA alkylation by PM occurs primarily 
at the N-7 position of guanine (Mehta et al., 1980) giving rise to the first product, a 
guanosine-PM adduct, which is unstable with a half-life of ~2–3 h (Mehta and Ludlum, 
1982). PM forms a mono-functional DNA adduct; N-(2-chloroethyl)-N-[2-(7-
guaninyl)ethyl]amine (NOR-G) and two bi-functional DNA adducts; N-(2-hydroxyethyl)-N-
[2-(N7-guaninyl)ethyl]-amine (NOR-G-OH) and N,N-bis[2-(N7-guaninyl)ethyl]amine (G-
NOR-G), both in vitro (Cushnir et al., 1990) and in vivo (Malayappan et al., 2010). The 
cross-linked adduct G-NOR-G is responsible for the cytotoxicity and teratological effects 
that contribute to the therapeutic uses of CPA/PM (Little and Mirkes, 1987).
Upon DSB induction, cells activate DNA damage responses (DDR) that comprise of cell 
cycle arrest, DNA damage repair, and subsequent cell cycle resumption or cell death (Giunta 
et al., 2010). One of the most immediate DDR events is phosphorylation of histone H2AX 
(γH2AX), considered the gold standard for localizing DSBs since it recruits and maintains 
DNA repair molecules at damage sites until repair is completed (Svetlova et al., 2010). 
Some DDR proteins activated due to DSBs include ataxia–telangiectasia mutated (ATM), 
ATM related (ATR) and DNA-dependent protein kinases (DNA-PKs) (Svetlova et al., 2010). 
DNA DSBs can be repaired by both the non-homologous end joining (NHEJ; Chiruvella et 
al., 2012) and homologous recombination (HR; Scully et al., 1997) pathways.
The granulosa cell is the somatic cell component of the oocyte-containing follicle, and close 
association between the granulosa cell and oocyte is required for follicular development. 
Some functions of granulosa cells include the production of sex steroids (Bjersing and 
Carstensen, 1967) and a myriad of growth factors that interact with the oocyte during 
development (Forde et al., 2008). Loss of granulosa cells during preantral and antral stages 
of follicular development leads to a premature reduction in female fecundity through 
reduced follicle health and oocyte viability (Walters et al., 2012). An in vivo study 
demonstrated that the destruction of granulosa cells by the PM parent metabolite, CPA, 
potentially occurs through oxidative stress-induced DNA damage leading to apoptosis in rats 
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(Lopez and Luderer, 2004). Additionally, PM has been shown to induce DNA damage in 
exposed ovaries of mice and rats (Petrillo et al., 2011). In this current study, we 
hypothesized that PM causes DNA adduct formation which precipitates the granulosa cell 
towards demise due to DNA damage induction. In addition, we proposed that the DDR 
would be induced to counteract PM-induced ovarian DNA damage.
Methods and materials
Reagents
Phosphoramide mustard (PM) was obtained from the National Cancer Institute (Bethesda, 
MD). 2-β-Mercaptoethanol, 30% acrylamide/0.8% bisacrylamide, ammonium persulfate, 
glycerol, N′N′N′N′-tetramethylethylenediamine (TEMED), Tris base, Tris HCL, sodium 
chloride, Tween-20, bis-2-chloroethylamine hydrochloride, 2′-deoxyguanosine, dimethyl 
sulfoxide (DMSO) and sodium acetate were purchased from Sigma-Aldrich Inc. (St. Louis, 
MO). Dulbecco’s Modified Eagle Medium (D-MEM)/F12 (1×), 0.25% trypsin-
ethylenediaminetetraacetic acid (EDTA), Pen Strep and fetal bovine serum (FBS) were from 
Gibco by Life Technologies (Grand Island, NY). Millicell-EZ slides were from Millipore 
(Bedford, MA). A Corning vacuum filter/storage system and cell culture flasks were 
purchased from Corning Inc. (Corning, NY). RNeasy Mini Kit, QIAshredder Kit, RNeasy 
MinElute Kit, Quantitect™ SYBR Green PCR Kit and Blood and Cell Culture DNA Mini 
Kit were purchased from Qiagen Inc. (Valencia, CA). All primers were purchased from the 
Iowa State University DNA facility. All primary antibodies were purchased from Abcam 
(Cambridge, MA). RNAlater was obtained from Ambion Inc. (Austin, TX). The polyclonal 
goat anti-rabbit secondary was obtained from Pierce Biotechnology (Rockford, IL). Ponceau 
S was from Fisher Scientific. An ECL Plus chemical luminescence detection kit was 
obtained from GE Healthcare, Amersham (Buckinghamshire, UK).
Rat spontaneously immortalized granulosa cell culture
A spontaneously immortalized clonal granulosa cell (SIGC) line derived from primary rat 
ovarian granulosa cell cultures were obtained as a gift from Dr. Burghardt at Texas A&M 
University. SIGC (2.5 × 104 cells) were cultured in 25-cm2 flasks in media (DMEM/F12 
plus 5% FBS and 50 mg/ml of Pen Strep) at 37 °C and 5% CO2 until 80% confluent.
Cell viability
SIGCs were treated with DMSO and/or PM (0.5 μM, 1 μM, 3 μM or 6 μM) for 48 h to 
perform cell viability measurements (n = 3 per treatment). Cells were harvested by 
trypsinization and 100 μl of the cell suspension was stained with Trypan blue (1:1). Trypan 
blue selectively penetrates cell membranes of dead cells, coloring them blue, whereas it is 
not absorbed by membranes of live cells, thus excluding live cells from staining. Cell 
counting was performed using a hemocytometer and the percentage of viable cells 
calculated. Since it is difficult to ascertain the level of PM reaching the ovary in CPA-treated 
patients, we used a bioassay endpoint approach in which ~20% depletion of cell viability 
was achieved and DNA adduct formation as well as gene and protein assays were performed 
at preceding time points.
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DNA isolation and mass spectrometry
Cells were harvested by trypsinization and pelleted by centrifugation at 1200 rpm for 5 min, 
washed twice in phosphate buffer saline (PBS) and resuspended in cold PBS (4 °C). DNA 
was isolated from cells using a Qiagen blood and cell culture DNA kit according to the 
manufacturer’s protocol. DNA concentration was determined using NanoDrop (λ = 260/280 
nm; ND 1000; Nanodrop Technologies Inc., Wilmington, DE). Internal standards of NOR-
G-OH (DNA adduct 1; DA1) and G-NOR-G (DNA adduct 2; DA2) were prepared according 
to a modified procedure (Hemminki, 1985; Malayappan et al., 2010). DNA samples from 
cell lines (10–50 μg in 200 μl of buffer) were used to perform Agilent QTOF6540 LC/MS 
analysis at the Iowa State University Chemical Instrumentation Facility. Each sample (1 μl) 
was injected into the JetStream ESI ion source and water/MeOH (20/80) was used as 
effluent solvent. The LC column used in this experiment was C18, 4.6 * 150 mm, 1.8 μm. 
Accurate mass measurement was achieved by constantly infusing a calibrant (masses: 
121.0508 and 922.0098). Detection of PM-DNA adducts were performed once.
Immunofluorescence
Cells (1 × 105 cells/well) were transferred to Millicell-EZ slide wells (Millipore, Bedford, 
MA) and treated with DMSO ± PM (3 or 6 μM) for 24 or 48 h (n = 3 per timepoint/
treatment). Cells were washed with PBS three times and fixed with 95% ethanol for 5 min 
on ice, followed by incubation in 0.25–0.5% Triton X-100 containing PBS for 10 min to 
permeabilize the membranes. After washing, slides were blocked with 5% normal serum in 
PBS for 1 h and washed again with PBS. Slides were incubated with a primary antibody 
directed against γH2AX (1:50) overnight at 4 °C. After washing in PBS, slides were 
incubated with a donkey anti-rabbit IgG-FITC secondary antibody (1:3000) for 1 h. Slides 
were then counterstained with 4–6-diamidino-2-phenylindole (DAPI). Images were taken 
using a Leica fluorescent microscope and the percentage of cells with foci for γH2AX was 
calculated (n = 3 slides/treatment). Total cell number per slide was approximately 150.
RNA isolation and qRT-PCR
SIGCs were treated with DMSO ± PM (3 or 6 μM) for 24 or 48 h (n = 3 per timepoint/
treatment). RNA was isolated using an RNeasy Mini Kit and the concentration was 
determined using NanoDrop (λ = 260/280 nm; ND 1000; Nanodrop Technologies Inc., 
Wilmington, DE). Total RNA (1 μg) was reverse transcribed to cDNA utilizing the 
Superscript III One-Step qRT-PCR. Diluted cDNA (2 μl; 1:20) was amplified on an 
Eppendorf PCR Master cycler using a Quantitect™ SYBR Green PCR Kit (n = 3 samples 
per treatment/timepoint; n = 3 repetitions per sample). Primers for Atm, Prkdc, Xrcc6, 
Parp1, Rad51, Brca1 and Gapdh were designed by Primer 3 Input Version (0.4.0) (Table 1). 
The regular cycling program consisted of a 15 min hold at 95 °C and 45 cycles of denaturing 
at 95 °C for 15 s, annealing at 58 °C for 15 s, and extension at 72 °C for 20 s at which point 
data were acquired. Each sample was normalized to Gapdh before quantification using the 
2−ΔΔCt method (Livak and Schmittgen, 2001; Pfaffl, 2001)
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Protein isolation and Western blot
SIGCs were treated with DMSO ± PM (3 or 6 μM) for 24 or 48 h (n = 3 per timepoint/
treatment) and protein isolated using lysis buffer containing protease and phosphatase 
inhibitors as previously described (Ganesan et al., 2013). Briefly, cells were placed on ice 
for 10 min, followed by two rounds of centrifugation at 10,000 rpm for 15 min and protein 
concentration was measured using a BCA protocol. Protein was stored at −80 °C until 
further use. SDS-PAGE was used to separate the proteins and then transferred to a 
nitrocellulose membrane. Membranes were blocked for 1 h in 5% milk in Tris-buffered 
saline containing Tween-20. Membranes were incubated in one of: anti-PARP-1 antibody 
(1:200), anti-ATM antibody (1:100), anti-rabbit phosphorylated H2AX antibody (γH2AX; 
1:100), anti-rabbit BRCA1 antibody (1:500), anti-rabbit PRKDC antibody (1:100), anti-
RAD 51 antibody (1:500) and anti-mouse XRCC6 antibody (1:100) for 36 h at 4 °C. 
Following three washes in TTBS (1×), membranes were incubated with a species specific 
secondary antibody (1:2000) for 1 h at room temperature. Membranes were washed three 
times in TTBS and one time in TBS and then incubated in an enhanced chemiluminescence 
(ECL) detection substrate for 5 min and exposed to X-ray film. Densitometry of the 
appropriate bands was performed using ImageJ software (NCBI). Background densitometry 
values were subtracted and protein of interest densitometry values were normalized to those 
of Ponceau S.
Statistical analysis
Data were analyzed by unpaired t-tests comparing treatment with control raw data at each 
individual time-point using Prism 5.04 software (Graph Pad Software). Where there are 
more than two treatments (mRNA and protein), ANOVA was utilized (Graph Pad Software). 
Statistical significance was defined as P < 0.05. For graphical purposes, protein expression is 
presented as a mean ± SE of the respective control.
Results
Cell viability was impacted by PM exposure
SIGCs were treated with DMSO or PM (0.5, 1, 3 or 6 μM) for 48 h and cell viability was 
quantified using Trypan blue staining. PM reduced (P < 0.05) cell viability at concentrations 
of 3 μM and higher. Relative to control, the percentage of viable cells was 91% and 83.6% 
after exposure to 3 μM and 6 μM PM, respectively (Fig. 2). (See Fig. 1.)
PM exposure induces DNA adduct formation
SIGCs were treated with DMSO or PM (3 or 6 μM) for 12, 24 or 48 h and LC/MS analysis 
was performed. DA1 (Fig. 3A, B; mol. weight = 239) was observed after 24 h of exposure to 
6 μM PM, while DA2 (Fig. 3C, D; mol. weight = 372) was formed after 48 h with both the 3 
and 6 μM PM exposures.
DNA damage was induced by PM exposure as determined by localization of γH2AX
SIGCs were treated with DMSO or PM (3 or 6 μM) for 24 or 48 h to perform γH2AX 
protein localization (Fig. 4A–C) using immunofluorescence. The percentage of cells with 
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positive γH2AX foci were increased (P < 0.05) by the 6 μM PM exposure after 24 h, relative 
to control treated cells. After 48 h of PM exposure (both concentrations) increased levels of 
γH2AX foci were observed (Fig. 4D).
PM exposure increases DDR gene mRNA expression level
Following 24 h of PM exposure, the DDR genes Atm, Parp1, Prkdc, Xrcc6, and Brca1 and 
Rad51 mRNA expression were increased (P < 0.05) after 6 μM concentration compared to 
both control and cells exposed to 3 μM PM. Atm, Parp1, Prkdc, Xrcc6, Brca1 and Rad51 
mRNA expression were decreased (P < 0.05) by 3 μM PM exposure after 24 h compared to 
both control and 6 μM PM treated cells (Fig. 5A).
After PM exposure for 48 h, mRNA abundance of the DNA repair response genes Atm, 
Parp1, Prkdc, and Brca1 and Rad51 mRNA expression were increased (P < 0.05) at 3 μM 
concentration while no changes in Xrcc6 mRNA expression were observed compared to 
control and 6 μM PM. At the same time Atm, Parp1, and Brca1 were increased at the 6 μM 
PM concentration compared to control and 3 μM PM. No changes were detected in Prkdc, 
Xrcc6, or Rad51 mRNA expression at 3 μM compared to control and 6 μM PM exposure 
(Fig. 5B).
DDR proteins were increased in response to PM exposure
Following 24 h of PM exposure, the DDR proteins γH2AX, ATM, PRKDC, XRCC6 and 
RAD51 were increased (P < 0.05) by exposure to 6 μM PM. BRCA1 and PARP-1 were 
increased (P < 0.05) by both concentrations of PM compared to control. In contrast, PRKDC 
and RAD51 were decreased (P < 0.05) by 3 μM PM compared to both control and 6 μM PM 
treatments (Fig. 6A).
After 48 h of PM exposure, the DDR proteins γH2AX, ATM, PARP-1, PRKDC and BRCA1 
were increased (P < 0.05) at both PM concentrations compared to control while XRCC6 
protein was decreased (P < 0.05) by 6 μM, but not 3 μM, PM concentration. RAD51 protein 
was not altered by either concentration of PM compared to control (Fig. 6B).
Discussion
In the current study, we describe DNA adduct formation followed by the appearance of DNA 
DSBs which occurs after PM exposure. In addition, we illustrate the subsequent induction of 
the DDR in a rat ovarian SIGC line. Our rationale for these studies was that CPA has been 
reported to destroy ovarian follicles by targeting granulosa cells in mice and rats (Desmeules 
and Devine, 2006). Biotransformation of CPA to PM, the anti-neoplastic and ovotoxic form, 
has been described (Plowchalk and Mattison, 1991) and it is recognized that PM can be 
detected in the urine of CPA-treated patients, approximately 3 h following exposure at levels 
of 50–100 nmol/ml (Jardine et al., 1978). Using an in vitro ovarian culture system, we have 
previously reported that PM induces follicle loss after 4 days of exposure (Madden et al., 
2014). Also, evidence supporting that PM induces DNA DSBs was shown in oocyte and 
granulosa cell nuclei (Petrillo et al., 2011). In addition, CPA-induced oxidative stress-
induced DNA damage has been described (Tsai-Turton et al., 2007). Additionally, we have 
reported that PM is metabolized to a volatile ovotoxicant, 2-chloroethylaziridine (CEZ; 
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Madden et al., 2014), with a longer half-life than PM (Lu and Chan, 1996), therefore, PM 
exposed ovaries can be considered to also be exposed to CEZ.
It is known that the cytotoxic properties of PM occur by the formation of DNA adducts, 
thereby preventing cell division by inhibiting DNA strand separation (Cushnir et al., 1990), 
required for cancer cell destruction. In addition, the cross-linked adduct DA2 is responsible 
for the cytotoxicity and teratological effects of CPA (Little and Mirkes, 1987) and these 
events are required for tumor destruction. PM formed the DA2 adduct in exposed rat 
embryos (Mirkes et al., 1992) as well as in white blood cells of cancer patients (Malayappan 
et al., 2010). PM-induced cell death was observed in granulosa cells after 48 h. PM binds to 
DNA to first form DA1 at a higher PM concentration after 24 h of exposure followed rapidly 
by the formation of DA2, observed in both PM exposures after 48 h. Thus, these results lend 
support to our proposal that DNA adduct formation is involved in the ovotoxic, in addition to 
the anti-neoplastic properties of PM.
To next evaluate whether DNA damage occurs in granulosa cells after PM-induced DNA 
adduction, we determined any alterations to ATM, a protein kinase that is recruited and 
activated upon DNA DSB. Increased Atm mRNA and protein were observed after 24 h of 
exposure to 6 μM PM, and by both PM concentrations after 48 h, indicating a dose-and 
time-dependent impact of PM on Atm induction. A number of chemicals including CPA 
activate ATM signaling eventually resulting in apoptosis in extra-ovarian mammalian cells 
(Ganesan et al., 2013; Toulany et al., 2014). ATM phosphorylates histone H2AX in response 
to DNA DSBs (Burma et al., 2001) and γH2AX protein was previously localized within the 
oocyte and granulosa cell of PM exposed mouse ovaries (Petrillo et al., 2011). Both ATM 
activation and γH2AX appearance serve as proxy markers of cellular DNA damage (Tanaka 
et al., 2006). Thus, we determined if γH2AX was increased in granulosa cells post-PM 
exposure and show that PM increased the percentage of γH2AX-positive cells and also 
increased γH2AX protein in total ovarian protein homogenates in both a dose- and time-
dependent manner. These data indicate that DNA damage is induced by PM exposure after 
DNA adduct formation in rat ovarian granulosa cells.
In order to next sequentially follow whether DNA DSB induction results in a protective 
response in the form of the DDR within granulosa cells, we quantified changes in 
poly(ADP-ribose) polymerase-1 (PARP-1) which is rapidly activated by DNA DSBs. 
Additionally, PARP-1 is involved in posttranslational modification of nuclear proteins during 
DNA damage and activates cellular processes such as DNA replication, DNA repair, 
apoptosis and genome stability (Yu et al., 2002). We demonstrate that Parp1 mRNA and 
protein were increased in a similar manner to that observed in Atm — by 6 μM PM after 24 
h of PM exposure and by both PM concentrations after 48 h. We also found that ATM 
protein level was coincident with PARP-1 protein level after PM exposure. A link between 
ATM and PARP-1 has been previously found; PARP-1 deficient mice were extremely 
sensitive to low doses of γ-radiation, and this phenotype could be ascribed to a deficient 
ATM-kinase activation in tissues such as the intestine epithelium (de Murcia et al., 1997).
PARP-1 competes with XRCC6 to repair a DSB as part of the NHEJ pathway but, in 
contrast, PARP-1 can also be recruited to a DSB in the absence of XRCC6 when the 
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classical pathway of NHEJ is absent (Wang et al., 2006). XRCC6 is a KU protein which 
forms a heterodimer with XRCC5 (Calsou et al., 2003). A deficiency of XRCC6 protein 
causes genomic instability and malignant formation (Wang et al., 2013). We found that 
Xrcc6 mRNA was reduced by the lower PM exposure after 24 h, but increased by the 6 μM 
PM concentration at the same time point. Subsequently, Xrcc6 mRNA in 3 μM PM-treated 
cells returned to control levels, while it was reduced at the higher PM concentration. XRCC6 
protein levels were initially increased by the 6 μM PM exposure, but subsequently 
decreased. These results indicate that there is a dynamic response of Xrcc6 mRNA to PM 
exposure, and may suggest that XRCC6 is involved in the earlier DDR via the NHEJ repair 
pathway, but at later times of exposure, and that PARP-1 could potentially compete with 
XRCC6 to repair DNA damage through an XRCC6-independent DNA repair pathway; 
however, these possibilities cannot be confirmed by the current study.
We found a dose-dependent temporal pattern of Prkdc mRNA and protein increased 
expression in response to PM exposure. Our study also indicates that PM could induce 
PRKDC as part of the mechanism to repair DNA damage and possibly result in improved 
survivability of SIGCs. PRKDC is a DNA-dependent protein kinase recruited and activated 
at the site of DNA damage by KU proteins to repair DSBs repaired by NHEJ pathways. 
Interestingly, capsaicin-induced autophagy of MCF-7 cells was shown to occur via 
activation of the PRKDC, ATM and PARP-1 DDR proteins (Yoon et al., 2012). Further, 
increased ionizing radiation-induced Prkdc mRNA was observed in mouse leukemic 
monocyte macrophage cell line RAW264.7 and was thought to be involved in the prevention 
of cell death (Dhariwala et al., 2012).
We also observed a temporal pattern of increased Brca1 mRNA and protein due to PM 
exposure, supporting that the HR DDR pathway is induced and that ovarian Brca1 is 
responsive to PM exposure. BRCA1 is a breast cancer protein required for repair of DSBs 
via the HR pathway. Previously, we have found that Brca1 mRNA and protein were 
increased in response to a chemical exposure (7,12-dimethylbenz[a]anthracene) that induced 
DSBs in rat ovaries (Ganesan et al., 2013). In cells that were resistant to 5-azacytidine 
activation of ATM and BRCA1 inhibited 5-azacytidine-induced apoptosis by repairing DNA 
damage but this activation of ATM and BRCA1 was absent in the parental 5-azacytidine-
sensitive leukemia cell line (Imanishi et al., 2014). Thus, these data support that Brca1 is 
involved in the ovarian response to PM exposure, likely as an attempt to prevent ovotoxicity.
We found that PM increased Rad51 mRNA and protein at the 6 μM PM concentration and 
that a similar response occurred with the 3 μM PM exposure, but this lagged from that of the 
higher concentration, again indicating a dynamic, temporal pattern of the DDR to PM 
exposure. BRCA1 can interact with RAD 51 during HR to regulate the function of RAD51 
in response to DSBs and block sister chromatid replication slippage (Cousineau et al., 2005). 
Downregulation of RAD51 previously indicated failure of the HR pathway in hypoxic 
cancer cells (Bindra et al., 2004). Also, Rad51 mRNA was elevated in tumor cells, 
suggesting that it plays a role in repair of DNA damage (Raderschall et al., 2002).
Taken together, these data demonstrate that PM exposure to an ovarian granulosa cell line 
caused formation of two DNA adducts. In addition, loss of cell viability and induction of the 
Ganesan and Keating Page 8
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2016 September 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
DDR, in both a time- and dose-dependent manner was observed in all of the genes and their 
protein products that were examined. There was apparent activation of both the NHEJ as 
well as the HR pathways of DNA repair, thus, one was not favored over another. 
Interestingly, the lower concentration of PM resulted in decreased mRNA levels for all genes 
investigated, despite there being no effect on the internal housekeeping gene used. 
Potentially this decline in mRNA levels may indicate a mechanism of ovotoxicity that is 
occurring at low level PM exposure, or may represent a time lag in mRNA induction that 
may have also occurred at an earlier time point at the 6 μM PM concentration. It is probable 
and likely that there are posttranslational modifications and regulatory pathways being 
induced that were outside the scope of this study. Activation of the DDR appears to be 
temporal, eventually returning to that of the control treated cells, which could represent that 
the DNA DSB has either been repaired, or that the cell has been shunted towards an atretic 
fate. However, the data reported herein may provide initial targets for amelioration of 
CPA/PM-induced infertility. Taken together, PM, the active metabolite of CPA, may induce 
ovarian follicle death via the formation of DNA adducts and the ovary induces mechanisms 
to respond to this genotoxic insult likely in order to protect the precious oocyte-containing 
follicle pool.
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Abbreviations
CPA cyclophosphamide
PM phosphoramide mustard
NOR-G-OH N-(2-hydroxyethyl)-N-[2-(N7-guaninyl)ethyl]-amine
NOR-G N-(2-chloroethyl)-N-[2-(7-guaninyl)ethyl]amine
G-NOR-G N-bis[2-(N7-guaninyl)ethyl]amine
SIGCs spontaneously immortalized granulosa cells
CEZ chloroethylaziridine
DNA-PKs DNA-dependent protein kinases
DDR DNA damage response
DSBs double-strand breaks
NHEJ non-homologous end joining
HR homologous recombination
EDTA ethylenediaminetetraacetic acid
FBS fetal bovine serum
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PBS phosphate buffered saline
ECL enhanced chemiluminescence
DMSO dimethyl sulfoxide
ATM ataxia telangiectasia mutated
ATR ATM-related
XRCC6 X-ray repair complementing defective repair in Chinese hamster cells 6
BRCA1 breast cancer type 1
RAD 51 Rad 51 homolog
PARP-1 poly(ADP-ribose) polymerase-1
PRKDC protein kinase, DNA-activated, catalytic polypeptide
γH2AX phosphorylated histone H2AX
TEMED N′N′N′N′-tetramethylethylenediamine
References
Anderson D, Bishop JB, Garner RC, Ostrosky-Wegman P, Selby PB. Cyclophosphamide: review of its 
mutagenicity for an assessment of potential germ cell risks. Mutat Res. 1995; 330:115–181. 
[PubMed: 7623863] 
Bindra RS, Schaffer PJ, Meng A, Woo J, Måseide K, Roth ME, Lizardi P, Hedley DW, Bristow RG, 
Glazer PM. Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer 
cells. Mol Cell Biol. 2004; 24:8504–8518. [PubMed: 15367671] 
Bjersing L, Carstensen H. Biosynthesis of steroids by granulosa cells of the porcine ovary in vitro. J 
Reprod Fertil. 1967; 14:101–111. [PubMed: 6033298] 
Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in 
response to DNA double-strand breaks. J Biol Chem. 2001; 276:42462–42467. [PubMed: 
11571274] 
Calsou P, Delteil C, Frit P, Drouet J, Salles B. Coordinated assembly of Ku and p460 subunits of the 
DNA-dependent protein kinase on DNA ends is necessary for XRCC4-ligase IV recruitment. J Mol 
Biol. 2003; 326:93–103. [PubMed: 12547193] 
Chemaitilly W, Mertens AC, Mitby P, Whitton J, Stovall M, Yasui Y, Robison LL, Sklar CA. Acute 
ovarian failure in the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2006; 91:1723–
1728. [PubMed: 16492690] 
Chiruvella KK, Sebastian R, Sharma S, Karande AA, Choudhary B, Raghavan SC. Time-dependent 
predominance of nonhomologous DNA end-joining pathways during embryonic development in 
mice. J Mol Biol. 2012; 417:197–211. [PubMed: 22306462] 
Cousineau I, Abaji C, Belmaaza A. BRCA1 regulates RAD51 function in response to DNA damage 
and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid 
cohesion, genome stability, and carcinogenesis. Cancer Res. 2005; 65:11384–11391. [PubMed: 
16357146] 
Cushnir JR, Naylor S, Lamb JH, Farmer PB, Brown NA, Mirkes PE. Identification of phosphoramide 
mustard/DNA adducts using tandem mass spectrometry. Rapid Commun Mass Spectrom. 1990; 
4:410–414. [PubMed: 2134189] 
de Murcia JM, Niedergang C, Trucco C, Ricoul M, Dutrillaux B, Mark M, Oliver FJ, Masson M, 
Dierich A, LeMeur M, Walztinger C, Chambon P, de Murcia G. Requirement of poly(ADP-ribose) 
Ganesan and Keating Page 10
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2016 September 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
polymerase in recovery from DNA damage in mice and in cells. PNAS. 1997; 94:7303–7307. 
[PubMed: 9207086] 
Desmeules P, Devine PJ. Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured 
mouse ovaries. Toxicol Sci. 2006; 90:500–509. [PubMed: 16381661] 
Dhariwala F, Narang H, Krishna M. Ionizing radiation induced signaling of DNA damage response 
molecules in RAW 264.7 and CD4+ T cells. Mol Cell Biochem. 2012; 363:43–51. [PubMed: 
22173400] 
Forde N, Mihm M, Canty MJ, Zielak AE, Baker PJ, Park S, Lonergan P, Smith GW, Coussens PM, 
Ireland JJ, Evans ACO. Differential expression of signal transduction factors in ovarian follicle 
development: a functional role for betaglycan and FIBP in granulosa cells in cattle. Physiol 
Genomics. 2008; 33:193–204. [PubMed: 18285519] 
Ganesan S, Bhattacharya P, Keating AF. 7,12-Dimethylbenz[a]anthracene exposure induces the DNA 
repair response in neonatal rat ovaries. Toxicol Appl Pharmacol. 2013; 272:690–696. [PubMed: 
23969067] 
Giunta S, Belotserkovskaya R, Jackson SP. DNA damage signaling in response to double-strand breaks 
during mitosis. J Cell Biol. 2010; 190:197–207. [PubMed: 20660628] 
Hemminki K. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system 
and in vivo in mice. Cancer Res. 1985; 45:4237–4243. [PubMed: 4028012] 
Himelstein-Braw R, Peters H, Faber M. Influence of irradiation and chemotherapy on the ovaries of 
children with abdominal tumours. Br J Cancer. 1977; 36:269–275. [PubMed: 911665] 
Hudson MM. Reproductive outcomes for survivors of childhood cancer. Obstet Gynecol. 2010; 
116:1171–1183. [PubMed: 20966703] 
Imanishi S, Umezu T, Ohtsuki K, Kobayashi C, Ohyashiki K, Ohyashiki JH. Constitutive activation of 
the ATM/BRCA1 pathway prevents DNA damage-induced apoptosis in 5-azacytidine-resistant cell 
lines. Biochem Pharmacol. 2014; 89:361–369. [PubMed: 24680865] 
Jardine I, Fenselau C, Appler M, Kan MN, Brundrett RB, Colvin M. Quantitation by gas 
chromatography–chemical ionization mass spectrometry of cyclophosphamide, phosphoramide 
mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide 
therapy. Cancer Res. 1978; 38:408–415. [PubMed: 620410] 
Larsen EC, Müller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-
term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 
2003; 88:5307–5314. [PubMed: 14602766] 
Little SA, Mirkes PE. DNA cross-linking and single-strand breaks induced by teratogenic 
concentrations of 4-hydroperoxycyclophosphamide and phosphoramide mustard in 
postimplantation rat embryos. Cancer Res. 1987; 47:5421–5426. [PubMed: 3477317] 
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR 
and the 2−ΔΔCT method. Methods. 2001; 25:402–408. [PubMed: 11846609] 
Lopez SG, Luderer U. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione 
and apoptosis. Free Radic Biol Med. 2004; 36:1366–1377. [PubMed: 15135172] 
Lu H, Chan KK. Gas chromatographic–mass spectrometric assay for N-2-chloroethylaziridine, a 
volatile cytotoxic metabolite of cyclophosphamide, in rat plasma. J Chromatogr B Biomed Appl. 
1996; 678:219–225. [PubMed: 8738025] 
Madden JA, Hoyer PB, Devine PJ, Keating AF. Involvement of a volatile metabolite during 
phosphoramide mustard-induced ovotoxicity. Toxicol Appl Pharmacol. 2014; 277:1–7. [PubMed: 
24642057] 
Malayappan B, Johnson LA, Nie B, Panchal D, Matter B, Jacobson P, Tretyakova N. Quantitative 
high-performance liquid chromatography–electrospray ionization tandem mass spectrometry 
analysis of bis-N7-guanine DNA–DNA cross-links in white blood cells of cancer patients 
receiving cyclophosphamide therapy. Anal Chem. 2010; 82:3650–3658. [PubMed: 20361772] 
Mehta JR, Ludlum DB. Trapping of DNA-reactive metabolites of therapeutic or carcinogenic agents 
by carbon-14-labeled synthetic polynucleotides. Cancer Res. 1982; 42:2996–2999. [PubMed: 
7093949] 
Mehta JR, Przybylski M, Ludlum DB. Alkylation of guanosine and deoxyguanosine by 
phosphoramide mustard. Cancer Res. 1980; 40:4183–4186. [PubMed: 7471059] 
Ganesan and Keating Page 11
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2016 September 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Minton SE, Munster PN. Chemotherapy-induced amenorrhea and fertility in women undergoing 
adjuvant treatment for breast cancer. Cancer Control. 2002; 9:466–472. [PubMed: 12514564] 
Mirkes PE, Brown NA, Kajbaf M, Lamb JH, Farmer PB, Naylor S. Identification of 
cyclophosphamide-DNA adducts in rat embryos exposed in vitro to 4-
hydroperoxycyclophosphamide. Chem Res Toxicol. 1992; 5:382–385. [PubMed: 1504261] 
Petrillo SK, Desmeules P, Truong TQ, Devine PJ. Detection of DNA damage in oocytes of small 
ovarian follicles following phosphoramide mustard exposures of cultured rodent ovaries in vitro. 
Toxicol Appl Pharmacol. 2011; 253:94–102. [PubMed: 21439308] 
Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids 
Res. 2001; 29:e45. [PubMed: 11328886] 
Phillips DH, Farmer PB, Beland FA, Nath RG, Poirier MC, Reddy MV, Turteltaub KW. Methods of 
DNA adduct determination and their application to testing compounds for genotoxicity. Environ 
Mol Mutagen. 2000; 35:222–233. [PubMed: 10737957] 
Plowchalk DR, Mattison DR. Phosphoramide mustard is responsible for the ovarian toxicity of 
cyclophosphamide. Toxicol Appl Pharmacol. 1991; 107:472–481. [PubMed: 2000634] 
Raderschall E, Stout K, Freier S, Suckow V, Schweiger S, Haaf T. Elevated levels of Rad51 
recombination protein in tumor cells. Cancer Res. 2002; 62:219–225. [PubMed: 11782381] 
Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM. Association of 
BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 1997; 88:265–275. [PubMed: 9008167] 
Svetlova MP, Solovjeva LV, Tomilin NV. Mechanism of elimination of phosphorylated histone H2AX 
from chromatin after repair of DNA double-strand breaks. Mutat Res. 2010; 685:54–60. [PubMed: 
19682466] 
Tanaka T, Halicka HD, Huang X, Traganos F, Darzynkiewicz Z. Constitutive histone H2AX 
phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants. Cell 
Cycle. 2006; 5:1940–1945. [PubMed: 16940754] 
Tsai-Turton M, Luong BT, Tan Y, Luderer U. Cyclophosphamide-induced apoptosis in COV434 
human granulosa cells involves oxidative stress and glutathione depletion. Toxicol Sci. 2007; 
98(1):216–230. [PubMed: 17434952] 
Toulany M, Mihatsch J, Holler M, Chaachouay H, Rodemann HP. Cisplatin-mediated 
radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition. Radiother 
Oncol. 2014; 111:228–236. [PubMed: 24857596] 
Walters KA, Middleton LJ, Joseph SR, Hazra R, Jimenez M, Simanainen U, Allan CM, Handelsman 
DJ. Targeted loss of androgen receptor signaling in murine granulosa cells of preantral and antral 
follicles causes female subfertility. Biol Reprod. 2012; 87(151):1–11.
Wang M, Wu W, Wu W, Rosidi B, Zhang L, Wang H, Iliakis G. PARP-1 and Ku compete for repair of 
DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res. 2006; 34:6170–6182. 
[PubMed: 17088286] 
Wang Z, Lin H, Hua F, Hu ZW. Repairing DNA damage by XRCC6/KU70 reverses TLR4-deficiency-
worsened HCC development via restoring senescence and autophagic flux. Autophagy. 2013; 
9:925–927. [PubMed: 23518600] 
Yoon JH, Ahn SG, Lee BH, Jung SH, Oh SH. Role of autophagy in chemoresistance: regulation of the 
ATM-mediated DNA-damage signaling pathway through activation of DNA–PKcs and PARP-1. 
Biochem Pharmacol. 2012; 83:747–757. [PubMed: 22226932] 
Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson 
VL. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing 
factor. Science. 2002; 297:259–263. [PubMed: 12114629] 
Ganesan and Keating Page 12
Toxicol Appl Pharmacol. Author manuscript; available in PMC 2016 September 30.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 1. 
Formation of phosphoramide mustard-induced DNA adducts. PM undergoes nonenzymatic 
degradation to produce nornitrogen mustard (NOR). Both PM and NOR alkylate guanine 
bases within DNA form guanine monoadducts, N-[2-(N7-guaninyl)ethyl]-N-[2-
hydroxyethyl]-amine (G-NOR-OH), and DNA–DNA cross-links, N,N-bis[2-(N7-guaninyl) 
ethyl] amine (G-NOR-G), although PM is considered the major DNA reactive metabolite.
Adapted from Malayappan et al. (2010).
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Fig. 2. 
Cell viability is impacted by PM exposure. SIGCs were treated with DMSO or PM (0.5, 1, 3 
or 6 μM) for 48 h. Trypan blue staining was used to determine the cell viability. Values 
represent % of viable cells ± SE. *P < 0.05; different from control (n = 3 per treatment/
timepoint). Loss of cell viability was observed at the 3 and 6 μM PM exposures.
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Fig. 3. 
PM exposure induces DNA adduct formation. SIGCs were treated with DMSO or PM (3 or 
6 μM) for 12, 24 or 48 h for DNA isolation. Agilent QTOF6540 liquid chromatography (LC) 
mass spectrometry (MS) analysis was performed to detect DA1 and DA2 formation. Internal 
standards of DA1 and DA2 were prepared according to a modified procedure (Hemminki, 
1985; Malayappan et al., 2010). Values represent the relative abundance of DNA adducts (1 
× 105 nucleotides). (A) Quantification of DA1 appearance: DA1 was observed after 24 h of 
exposure to 6 μM PM. (B) Quantification of DA2 appearance: DA2 was formed after 48 h at 
both the 3 and 6 μM concentrations. (C) LC/MS spectrum indicating the DA1 product of 239 
m. wt. (D) LC/MS spectrum indicating the DA2 product of 372 m. wt.
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Fig. 4. 
DNA damage was induced by PM exposure as determined by localization of γH2AX. 
SIGCs were treated with (A) DMSO, (B) 3 μM PM or (C) 6 μM PM for 24 or 48 h and 
γH2AX protein localized using immunofluorescence staining (A–C). Blue represents DAPI 
nuclear stain; red staining indicates a FITC labeled primary antibody against γH2AX 
protein. (D) Values represent % of γH2AX positive cells (out of a total of ~150 cells per 
slide) ± SE; n = 3 per treatment/timepoint. Different letters indicate difference from CT; P < 
0.05. γH2AX protein appearance indicates DNA DSB formation, which was subsequent to 
DNA adduct detection.
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Fig. 5. 
PM exposure increases DDR gene mRNA expression levels. RNA was isolated from SIGCs 
treated with DMSO or PM (3 or 6 μM) for (A) 24 h or (B) 48 h, followed by qRT-PCR (n = 
3 samples per treatment/timepoint; n = 3 repetitions per sample). Genes were normalized to 
Gapdh and values reported as fold change due to PM exposure relative to the control value 
of 1 ± SEM. Different letters represent differences between treatments; P < 0.05. Increased 
mRNA levels were observed in cells exposed to the 6 μM PM concentration at 24 h before 
the increase was evident in cells exposed to 3 μM PM at 48 h, indicating a temporal pattern 
of DDR gene induction in response to PM.
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Fig. 6. 
DDR proteins are generally increased in response to PM exposure. Total protein was isolated 
from SIGCs treated with DMSO or PM (3 or 6 μM) for (A) 24 h or (B) 48 h, followed by 
Western blotting (n = 3 per treatment/timepoint). All treatments were run on the same gel 
per timepoint (n = 3/treatment) as depicted in the blots presented. Ponceau S was used for 
normalization with protein of interest and values were reported as raw mean value ± SEM. 
Different letters indicate differences between treatments; P < 0.05. PM induced increased 
γH2AX, ATM, PARP-1, PRKDC, XRCC6, BRCA1, and RAD51 after 24 h of the 6 μM PM 
exposure, while the 3 μM PM exposure increased γH2AX, ATM, PARP-1, PRKDC, and 
BRCA1 after 48 h.
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Table 1
Primer sequences used for qPCR.
Genes Forward primer Reverse primer
Atm TCAGCAGCACCTCTGATTCTT AGACAGACATGCTGCCTCCT
Brca1 CCCTCTTAGTCTGCTGAGCT CCTTTGGGTGGCTGTACTGA
Parp1 AAGTGCCAGTGTCAAGGAGA ACAGGGAGCAAAAGGGAAGA
Prkdc GCCACAGACCCCAATATCCT TATCTGACCATCTCGCCAGC
Rad51 ATCCCTGCATGCTTGTTCTC CTGCAGCTGACCATAACGAA
Xrcc6 GATCTGACACTGCCCAAGGT TGCTTCTTCGGTCCACTCTT
Gapdh GTGGACCTCATGGCCTACAT GGATGGAATTGTGAGGGAGA
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